AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.

Nvidia's Q2 FY2025 results were strong, but Q3 may not exceed forecasts significantly, leading to a potential stock price ...

Grupo Financiero Galicia is benefiting from a rebound in private sector lending activity in Argentina. Market forecasts see ...

Savers Value Village, a major for-profit thrift retailer, shows modest revenue growth but mixed profitability, yet remains ...

The Magnificent Seven stocks’ growth rate is getting closer to that of the rest of the S&P 500 ( SP500 ).

As noted in today's Morning Lineup, the US dollar, among other assets, has continued to rise post-election. The Bloomberg ...

Explore how a surging dollar and rising interest rates could threaten gold's recent rally and impact its future performance.

Lucid Group reports strong Q3, yet losses continue to grow. Read why LCID stock is difficult to justify amid reliance on ...

IonQ aims to lead the quantum networking market with two key milestones achieved this year. Read more about IONQ stock here.

Declining inflation and potential changes in low-wage labor dynamics pose risks to Walmart's future performance. Read more on ...

Rolls-Royce's recent trading update continues to reflect progress, with developments in power systems and new markets looking ...

Robinhood Markets, Inc.'s surging post-election share price is met with skepticism due to overvaluation. Learn more about ...